Prevent Hair Loss &
Promote Hair Growth
With Happy Head
Prescription Grade Hair Growth Solution
We Get To The Root
of Hair Loss
Our Topical Medication Goes Where
Your Hair Grows, Not Your Mouth
Safer Than Oral Alternatives & More Effective Hair Regrowth.
Prescription Grade Medications All-In-One. Spironolactone or Finasteride, Minoxidil 6% & Retinoic Acid
Happy Head Works For Women Of All Ages.
Hair Regrowth For Only $79/month
Free Shipping, No Contract, Cancel Anytime
Customized Women Formula
Females Under 50
Spironolactone 1% + Minoxidil 6% + Retinoic Acid 0.01% + Hydrocortisone 1%
Females Over 50
Finasteride 0.1% + Minoxidil 6% + Retinoic Acid 0.01% + Hydrocortisone 1%
Apply Daily To Thinning Or Receding Areas And Watch The Magic Happen.
Our Topical Works
Our Proprietary Topical Formula Consists Of Prescription Grade Spironolactone 1% or
Finasteride 0.25% + Minoxidil 6% +Retinoic Acid.
Topical finasteride is clinically proven to grow hair. Our minoxidil and finasteride topical solution results show.
Topical Spironolactone has clinically been proven to regrow hair. 1, 2, 3, 4
Over the counter minoxidil (Rogain™) is 5%. Our minoxidil is prescription strength and is 8%, for better efficacy and improved results.
Clinical studies have shown better hair grow and improved efficacy when prescription retinoic acid is mixed with minoxidil.
Topical Spironolactone for Hair Loss
Spironolactone helps female pattern hair loss by competitively inhibiting androgen binding to intracellular receptors. In other words, it blocks testosterone binding to testosterone receptors. Testosterone is the hormone responsible for hair thinning. Typically, testosterone is converted into another hormone called dihydrotestosterone, also known as DHT. DHT is responsible for shrinking hair follicles and causing thinning and baldness. Spironolactone competes with testosterone to bind to the testosterone receptors. By doing so, it prevents testosterone from converting into DHT. By effectively reducing the levels of DHT, spironolactone helps to combat female pattern hair loss.
Topical finasteride is a clinically proven, modern, effective method of combating hair loss with possible lower systemic adverse effects, according to clinical studies. One of the main causes of hair loss is Dihydrotestosterone (DHT). DHT in the scalp causes miniaturization of hair follicles in patients suffering from androgenetic alopecia. Finasteride inhibits DHT formation in the scalp, reversing the miniaturization of hair follicles. Traditionally, patients would take oral finasteride for hair loss. Oral version exposes the body to unnecessary systemic exposure of finasteride. In contrast, topical finasteride is applied topically and not ingested. Research shows that when compared to the tablet form of 1mg finasteride, 0.25% topical finasteride exhibit similar remedial effects. Hence, like oral preparation, topical finasteride for hair loss works to reduce scalp and serum DHT levels, a higher amount of which is found in miniaturized hair follicles. According to clinical studies, topical finasteride may be a safer alternative to oral finasteride since it is not ingested.
Does topical finasteride really work? Yes. There are many clinical studies demonstrating the efficacy of topical finasteride for male pattern hair loss. For example, in a clinical trial study of 45 male patients, Hajheydari et al. (2009) compared oral finasteride 1mg vs topical finasteride 1% for a total of 6 months. Both the oral finasteride 1mg and the topical finasteride 1% showed statistically significant increase in total and terminal hair count after 4 months. Authors concluded that “the therapeutic effects of both finasteride gel and finasteride tablet were relatively similar to each other.” For a summary of current clinical studies, please read our blog post titled “Efficacy of Topical Finasteride: Review of Current Medical Literature.”
This innovative method reduces the levels of dihydrotestosterone (DHT) and hinders the miniaturization of hair follicles in patients suffering from androgenetic alopecia (AGA).
Finasteride is indicated for male pattern hair loss, known as androgenetic alopecia. It is a 5AR-inhibitor and prevents formation of DHT. Clinical study by Hajheydari et al. (2009) has shown an increase in terminal hair count after several months of topical finasteride use, demonstrating that topical finasteride can cause hair to regrow and increase hair density.
With daily application of topical finasteride, the results are typically seen within 6 months of use.
Since spironolactone is a prescription medication, it requires a doctor’s consultation and prescription. With Happy Head, the doctor’s consultation is free and included when you purchase topical spironolactone. Simply fill out the short medical survey, and a physician will review your medical history and determine your eligibility for our prescription medication. Once approved, the prescription is written, sent electronically to the pharmacy and the medication is shipped out to you in discreet packaging with FedEx 2-day delivery. You will also receive free continuous support from our physicians in case there are any questions or issues.
Results may vary per patient. Results are not guaranteed. Topical spironolactone mixed with minoxidil is a compounded prescription medication. Compounded medications are not FDA approved. Women who may become pregnant or who are pregnant or breastfeeding should avoid using spironolactone. Some side effects may include dizziness or lightheadedness, breast tenderness, breast enlargement, irregular periods, spotting between periods or elevated potassium levels. Spironolactone may increase potassium levels in your body, so patients should avoid foods that are high in potassium, such as bananas, coconut water or avocados. Please see the Drug Safety Information below for more information.
Confidence Is Only A Click Away
1. Famenini Shannon, BS, Slaught Christa, BS, Duan Lewei, MS, and Goh Carolyn, MD. Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy, J Am Acad Dermatol. 2015 Oct; 73(4): 705–706.
2. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466–73)
3. Hamza Abdel-Raouf, Usama F. Aly, Walid Medhat, Shimaa S. Ahmed, Rasha T. A. Abdel-Aziz. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study. Dermatologic Therapy. 2021;34:e14678.
4. AYMAN E. YOUSEF, M.D. AHMED S. ABDELSHAFY, M.D. and MOUSA A.S. ALMABROUK, M.Sc. Topical Finasteride versus Topical Spironolactone in the Treatment of Androgenetic Alopecia. Med. J. Cairo Univ., Vol. 88, No. 3, June: 1017-1022, 2020